Optimal treatment for chronic active Epstein-Barr virus disease: Editorial

Pediatric Transplantation

Volumn 13, Issue 4, 2009, Pages 393-396

  Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTHRACYCLINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 2; PREDNISONE; VIDARABINE; VINCRISTINE;

ANTIVIRAL THERAPY; CHRONIC ACTIVE EPSTEIN BARR VIRUS DISEASE; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; EDITORIAL; EPSTEIN BARR VIRUS; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE TRANSFUSION; LYMPHOKINE ACTIVATED KILLER CELL; NONHUMAN; PROTEIN BLOOD LEVEL; VIRUS INFECTION; VIRUS REPLICATION;

CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE;

EID: 65549120771     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01095.x     Document Type: Editorial

References (38)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000 : 343 : 481 492. (Pubitemid 30646489)
2. Straus SE. Acute progressive Epstein-Barr virus infections. Ann Rev Med 1992 : 42 : 437 449.
3. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001 : 98 : 280 286.
4. Kimura H, Hoshino Y, Hara S, et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005 : 191 : 531 539. (Pubitemid 40216668)
5. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003 : 187 : 527 533. (Pubitemid 36250015)
6. Ohga S, Nomura A, Takada H, et al. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection. J Med Virol 2004 : 74 : 449 458. (Pubitemid 39281644)
7. Wakiguchi H, Fujieda M, Matsumoto K, Ohara Y, Wakiguchi A, Kurashige T. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection. Acta Med Okayama 1988 : 42 : 137 142.
8. Sugaya N, Kimura H, Hara S, et al. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Infect Dis 2004 : 190 : 985 988. (Pubitemid 39120978)
9. Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 2001 : 64 : 141 148. (Pubitemid 32405402)
10. Fujieda M, Wakiguchi H, Hisakawa H, Kubota H, Kurashige T. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatr Jpn 1993 : 35 : 394 399. (Pubitemid 23293465)
11. Alfieri C, Ghibu F, Joncas JH. Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. Can Med Assoc J 1984 : 131 : 1249 1252. (Pubitemid 15218035)
12. Alfieri C, Joncas JH. Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J Virol 1987 : 61 : 3306 3309. (Pubitemid 17137685)
13. Sumazaki R, Kanegane H, Osaki M, et al. SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood 2001 : 98 : 1268 1270.
14. Katano H, Ali MA, Patera AC, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 2004 : 103 : 1244 1252. (Pubitemid 38168634)
15. Ito Y, Shibata-Watanabe Y, Ushijima Y, et al. Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection. J Infect Dis 2008 : 197 : 663 666.
16. Schooley RT, Carey RW, Miller G, et al. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 1986 : 104 : 636 643. (Pubitemid 16078467)
17. Ishida Y, Yokota Y, Tauchi H, et al. Ganciclovir for chronic active Epstein-Barr virus infection. Lancet 1993 : 341 : 560 561. (Pubitemid 23066118)
18. Kimura H, Morita M, Tsuge I, et al. Vidarabine therapy for severe chronic active Epstein-Barr virus infection. J Pediatr Hematol Oncol 2001 : 23 : 294 299. (Pubitemid 32662038)
19. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999 : 93 : 1869 1874. (Pubitemid 29128488)
20. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 2006 : 16 : 251 261. (Pubitemid 44140721)
21. Sakai Y, Ohga S, Tonegawa Y, et al. Interferon-alpha therapy for chronic active Epstein-Barr virus infection: Potential effect on the development of T-lymphoproliferative disease. J Pediatr Hematol Oncol 1998 : 20 : 342 346. (Pubitemid 28483344)
22. Fujisaki T, Nagafuchi S, Okamura T. Gamma-interferon for severe chronic active Epstein-Barr virus. Ann Intern Med 1993 : 118 : 474 475. (Pubitemid 23081064)
23. Kawa-Ha K, Franco E, Doi S, et al. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet 1987 : 1 : 154. (Pubitemid 17015834)
24. Savoldo B, Huls MH, Liu Z, et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 2002 : 100 : 4059 4066. (Pubitemid 35396873)
25. Kuzushima K, Yamamoto M, Kimura H, et al. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol 1996 : 103 : 192 198. (Pubitemid 126423587)
26. Hagihara M, Tsuchiya T, Hyodo O, et al. Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection. Int J Hematol 2003 : 78 : 62 68. (Pubitemid 36899904)
27. Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 2000 : 356 : 223 224. (Pubitemid 30446982)
28. Taketani T, Kikuchi A, Inatomi J, et al. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002 : 29 : 531 533. (Pubitemid 34428725)
29. Uehara T, Nakaseko C, Hara S, et al. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. Am J Hematol 2004 : 76 : 368 372. (Pubitemid 38988622)
30. Yoshiba F, Hagihara M, Tazume K, et al. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting. Bone Marrow Transplant 2003 : 32 : 107 110. (Pubitemid 36850288)
31. Gotoh K, Ito Y, Shibata-Watanabe Y, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 2008 : 46 : 1525 1534.
32. Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T-NK-cell lymphoproliferative disease. Bone Marrow Transplant 2003 : 31 : 105 111. (Pubitemid 36240501)
33. Ishimura M, Ohga S, Nomura A, et al. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. Am J Hematol 2005 : 80 : 207 212. (Pubitemid 41579543)
34. Iguchi A, Kobayashi R, Sato TZ, Nakajima M, Kaneda M, Ariga T. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr infction. J Pediatr Hematol Oncol 2006 : 28 : 254 256. (Pubitemid 43791836)
35. Miyamura T, Chayama K, Wada T, et al. Two cases of chronic active Epstein-Barr virus infection (CAEBV) in which EBV-specific cytotoxic T lymphocyte (CTL) was induced after allogeneic bone marrow transplantation. Pediatr Transplant 2008 : 12 : 588 592.
36. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996 : 87 : 1446 1457. (Pubitemid 26056909)
37. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu Rev Immunol 2007 : 25 : 587 617. (Pubitemid 46697918)
38. Bollard CM, Gottschalk S, Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 2007 : 110 : 2838 2845. (Pubitemid 350006936)